Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, announced the completion of a $110 million financing.

The round is led by Cowen Healthcare Investments, with participation from new investors Neuberger Berman, Hitachi Ventures, Laurion Capital, and Monashee Investment Management. Existing investors Northpond Ventures, aMoon, Khosla Ventures, Optum Ventures, Echo Health Ventures, and Alumni Ventures also are participating. To date, Scipher has raised $227 million.